Poster Presentations

Adjuvant endocrine therapy
P01 SUSHI DOMAIN-CONTAINING PROTEIN 3 IS A PREDICTOR OF ENDOCRINE THERAPY RESPONSE IN BREAST CANCER
Shorouk Makhlouf, UK
Breast Imaging
P02 RESIDUAL MICROCALCIFICATIONS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR EARLY BREAST CANCER: IMPLICATIONS FOR SURGICAL PLANNING AND LONG-TERM OUTCOMES
Joel Allotey, UK
P03 LOCALIZATION OF NON-PALPABLE BREAST LESIONS
Martina Costa, Italy
P04 DIAGNOSIS OF PRIMARY AND SECONDARY BREAST LYMPHOMA: SOME CASES FROM OUR INSTITUTE AND REVIEW OF THE LITERATURE
Martina Costa, Italy
DCIS
P05 HOW CAN WE PREDICT UPSTAGING TO INVASIVE BREAST CANCER AFTER A BIOPSY DIAGNOSIS OF DUCTAL CARCINOMA IN SITU?
Julia Riggi, Belgium
HER2 positive breast cancer
P06 MAKING OUTCOME-BASED PRICING A REALITY IN THE UK – A RETROSPECTIVE COMPARISON OF COST-BASED VS OUTCOME-BASED PRICING FOR TRASTUZUMAB EMTANSINE (KADCYLA) IN METASTATIC BREAST CANCER
Karim El-Shakankery, UK
Locoregional therapy
P07 IMPACT OF OMITTING ROUTINE INTRAOPERATIVE FROZEN SECTION IN SENTINEL NODE BIOPSY FOR BREAST CANCER
Youmna Abdelaziz, UK
P08 RECONSIDERING THE NEED FOR INTRAOPERATIVE FROZEN SECTION IN SENTINEL LYMPH NODE BIOPSY FOR EARLY BREAST CANCER IN BAHRAIN
Hussain Abdulla, Bahrain
P09 AXILLARY RECURRENCE IN NON-STANDARD VS STANDARD AXILLARY LYMPH NODE DISSECTION IN N2-N3 HER2+ AND TRIPLE NEGATIVE BREAST CANCER PATIENTS THAT UNDERGO NEOADJUVANT SYSTEMIC THERAPY
Sergio Aguilar-Villanueva, Mexico
P10 LOCO-REGIONAL TREATMENT IN METASTATIC BREAST CANCER
Emanuela Esposito, Italy
P11 LONG TERM PATIENT REPORTED OUTCOMES FOLLOWING THERAPEUTIC MAMMAPLASTY OVER 17 YEARS
Katherine Fairhurst, UK
P12 DOES USE OF INTRAOPERATIVE INDOCYANINE GREEN (ICG) IMAGING REDUCE THE RISK OF MASTECTOMY SKIN FLAP NECROSIS (MFN) IN IMMEDIATE DEEP INFERIOR EPIGASTRIC PERFORATOR (DIEP) BREAST RECONSTRUCTIVE SURGERY?
Xin Yi Foong, UK
P13 SURGICAL MANAGEMENT OF THE NODE POSITIVE AXILLA WITH TARGETED AXILLARY DISSECTION IN BREAST CANCER: A SINGLE CENTRE EXPERIENCE OVER 6 YEARS OF PRACTICE
Chia Yin Goh, UK
P14 POST MASTECTOMY RECONSTRUCTION PRACTICES AND OUTCOMES FOR OLDER WOMEN IN A UK TERTIARY CARE CENTRE
Junaid Zia Hashmi, UK
P15 IMPLANT RECONSTRUCTION: TO MESH OR NOT TO MESH?
Kate Homyer, UK
P16 ONCOLOGICAL AND COSMETIC OUTCOMES OF LOCAL PERFORATOR FLAPS IN ONCOPLASTIC BREAST SURGERY; SINGLE CENTRE EXPERIENCE IN UK
Huma Irshad, UK
P17 ARE WE PERFORMING DIFFERENT TYPES OF OPERATION IN OUR OLDER BREAST CANCER PATIENTS COMPARED TO OUR YOUNGER BREAST CANCER PATIENTS?
David John, UK
P18 POST-CHEMOTHERAPY AXILLARY CONSERVATION SURGERY – UTILITY OF PRE-OPERATIVE AXILLARY ULTRASOUND AND INTRA-OPERATIVE FROZEN SECTION
Shalaka Joshi, India
P19 RESULTS OF THE INFLUENCE TRIAL: A STUDY COMPARING INDOCYANINE GREEN (ICG) FLUORESCENCE COMBINED WITH A STANDARD TRACER VERSUS ICG ALONE FOR SENTINEL NODE BIOPSY IN EARLY BREAST CANCER
Rahul Kanitkar, UK
P20 CHEST WALL PERFORATOR BASED FLAPS FOR PARTIAL BREAST RECONSTRUCTION AFTER BREAST CONSERVATION SURGERY: A CASE SERIES
Anupama Mane, India
P21 EXPLORING THE LANDSCAPE OF LOCOREGIONAL THERAPY DE-ESCALATION IN EARLY BREAST CANCER: A SYSTEMATIC REVIEW
Stuart Andrew McIntosh, UK
P22 BORDERLINE PHYLLODES TUMOUR IN 10-YEAR-OLD PREPUBERTAL FEMALE PRESENTING WITH NON-TENDER DISCRETE BREAST LUMP: A CASE REPORT
Kathryn McKnight, Ireland
P23 ONCOLOGICAL OUTCOMES OF LARGE VOLUME PARTIAL BREAST RESECTIONS RECONSTRUCTED WITH LATTISSIMUS DORSI FLAP OR THERAPEUTIC MAMMOPLASTY
Ankita Nirpharake, India
P24 SHOULD WE ADOPT NO CANCER ON INK? AN AUDIT OF MARGIN RE-EXCISION RATES AGAINST ASCO AND ABS GUIDELINES
Francesca Peters, UK
P25 DELAYED POST-BIOPSY TO SURGERY INTERVAL TENDS TO INCREASE AXILLARY NODAL METASTASIS, ESPECIALLY IN EARLY BREAST CANCER PATIENTS
Phatcharawan Prasitviset, Thailand
P26 PIONEERING BREAST CANCER EDUCATION IN EGYPT: INSIGHTS FROM THE FIRST ADVANCED ONCOPLASTIC BREAST SURGERY SKILLS COURSE BY THE EGYPTIAN GROUP OF BREAST SURGEONS
Ibrahim Sallam, UK
P27 ADVANCING BREAST RECONSTRUCTION: LICAP FLAP OPTIMIZATION TO ACHIEVE SUPERIOR NIPPLE AND BREAST SYMMETRY
Ibrahim Sallam, UK
P28 IS COMPLETION AXILLARY NODE CLEARANCE OF ANY VALUE TO GUIDE ADJUVANT TREATMENT CHOICE? OUTCOMES OF AN AUDIT
Mahmoud Soliman, UK
P29 LATE TOXICITY AFTER ADJUVANT WHOLE BREAST ULTRA-HYPOFRACTIONATED RADIOTHERAPY WITH SIB: A MATCHED PAIR ANALYSIS BETWEEN OPEN CAVITY AND ONCOPLASTIC SURGERY
Ranjan Subramani, India
P30 FLUORESCENT-GUIDED SURGERY IN ECTOPIC BREAST SURGERY: NODAL STAGING
Alessio Vinci, UK
P31 RADIATION THERAPY FOR CONTRALATERAL INTERNAL MAMMARY LYPMH NODES
Masahiro Yoshida, Japan
Molecular assays
P32 PREDICTION OF HER2 POSITIVE BREAST CANCER PATIENTS RESPONSE TO ANTI-HER2 THERAPY USING MRNA LEVEL
Nehal Atallah, UK
P33 THE IMPACT OF ONCOTYPE DX TESTING ON ADJUVANT CHEMOTHERAPY DECISION MAKING IN BREAST CANCER WITH SENTINEL LYMPH NODE MICROMETASTASIS
Sendhil Rajan, UK
Neoadjuvant therapy
P34 MANAGEMENT OF A LYMPH NODE POSITIVE AXILLA AFTER NEO-ADJUVANT CHEMOTHERAPY FOR BREAST CANCER: A SINGLE CENTRE EXPERIENCE
Khalid Amin, UK
P35 PATHOLOGICAL COMPLETE RESPONSE RATE AS A PROGNOSTIC FACTOR ACROSS MOLECULAR SUBTYPES OF BREAST CANCER: INSIGHTS FROM REAL WORLD DATA!
Mitchelle Engineer, India
P36 EMERGING TECHNOLOGIES FOR MONITORING BREAST CANCER RESPONSE TO NEOADJUVANT CHEMOTHERAPY: A SCOPING REVIEW
Thomas Hubbard, UK
P37 USING RAMAN SPECTROSCOPY TO DIFFERENTIATE TREATMENT RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER
Thomas Hubbard, UK
P38 NEOADJUVANT ENDOCRINE THERAPY: A SINGLE CENTRE STUDY EXAMINING THE USE OF NEOADJUVANT ENDOCRINE THERAPY IN ER+VE BREAST CANCER PATIENTS
Harsimran Kaur Surinder Singh, UK
Precision oncology
P39 LABEL-FREE IMPEDIMETRIC BIOSENSOR BASED ON DNA CHARACTERIZATION FOR HUMAN SAMPLES WITH BREAST CANCER
Leticia Arias, Mexico
P40 MODULATORS OF RESPONSE TO TRASTUZUMAB-BASED CHEMOTHERAPY IN HER2-POSITIVE BREAST CANCER
Nehal Atallah, UK
P41 HEMATOLOGICAL AND BIOCHEMICAL MARKERS INFLUENCING BREAST CANCER RISK AND MORTALITY: PROSPECTIVE COHORT STUDY IN THE UK BIOBANK BY MULTI-STATE MODELS
Xiaoxi Huang, China
P42 CHARACTERISATION OF PLEOMORPHIC LOBULAR CARCINOMA: AN IMAGE ANALYSIS-ASSISTED STUDY
Shorouk Makhlouf, UK
P43 INTEGRATION OF MULTI-OMICS DATA FOR PERSONALIZED TREATMENT IN TRIPLE-NEGATIVE BREAST CANCER
Eugenie Tseuh Tabe, Cameroon
Prevention
P44 SHOULD WE BE MARKING THE AXILLA WITH DELAYED SENTINEL NODE TRACERS IN RISK REDUCING MASTECTOMIES (RRM)?
Youmna Abdelazi, UK
P45 PATIENT PARTICIPATION IN BRIEF LIFESTYLE INTERVENTION AND UNDERSTANDING OF MODIFIABLE RISKS FACTORS IN BREAST CANCER: AGREEABLE AND EFFECTIVE?
Katy Homyer, UK
P46 A CASE REPORT OF MALE BREAST CANCER 29 YEARS AFTER TOTAL BODY IRRADIATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
Kezia Summers, UK
Screening
P47 USE OF A WIRELESS RADAR LOCALISATION DEVICE TO STREAMLINE PATIENT CARE
Gauri Babu, UK
P48 THE IMPACT OF BREAST DENSITY NOTIFICATION ON ANXIETY IN SOUTH AUSTRALIAN WOMEN UNDERGOING BREAST CANCER SCREENING
Wendy Ingman, Australia
P49 REDUCING AXILLARY SURGERY IN ELDERLY PATIENTS WITH SMALL BREAST CANCERS
Victor Lim, UK
P50 LARGE VOLUME EXTENSIVE SAMPLING (LVES) AS FIRST LINE BIOPSY TECHNIQUE IN SELECTED GROUP OF CASES IN BREAST SCREENING PROGRAMME
Archana Seth, UK
Symptom management
P51 ANTIBIOTIC PROPHYLAXIS AGAINST SURGICAL SITE INFECTION FOR ELECTIVE BREAST SURGERY
Abdulaziz Alshamlan, Saudi Arabia
P52 GYNAECOMASTIA REFERRAL PATHWAY – TIME FOR A CHANGE
Abdelbari Gdeh, UK
P53 USAGE OF BRACKETED MAGSEED (TWO OR MORE) FOR BREAST WIDE LOCAL EXCISION IN MULTIFOCAL OR MULTICENTRIC BREAST CANCER (MFBC/MCBC) COMBINED WITH PARTIAL BREAST RECONSTRUCTION USING PERFORATOR FLAPS
Akram Girgis, UK
P54 POSTOPERATIVE COMPLICATIONS FOLLOWING BREAST AUGMENTATION MASTOPEXY SURGERY ABROAD AND ITS IMPACT ON NATIONAL HEALTH SERVICE (CASE REVIEW)
Akram Girgis, UK
P55 IDENTIFYING RESEARCH PRIORITIES FOR IMPROVING INFORMATION AND SUPPORT FOR PATIENTS UNDERGOING BREAST CANCER SURGERY: A UK PATIENT-CENTRED PRIORITY SETTING PARTNERSHIP
Stuart McIntosh, UK
Triple negative breast cancer
P56 NAVIGATING SYNCHRONOUS BREAST AND COLON CANCER: MULTIDISCIPLINARY MANAGEMENT OF LOW ESTROGEN RECEPTOR-POSITIVE TUMOR – A CASE REPORT
Farah Bani-Khaled, Jordan
P57 INFLAMMATORY BREAST CANCER – SINGLE CENTER EXPERIENCE IN BANGLADESH
Sadia Siddiky, UK

 

Skip to content